Telemedicine Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Friedrich Schiller University, Germany
Hypertensive heart disease shows altered phospholipid metabolism by P-31-MR spectroscopic imaging
September 13th, 2006
Hypertensive heart disease shows an altered phospholipid metabolism correlated with a reduced left ventricular ejection fraction by P-31-MR spectroscopic imaging. Investigators working in Germany report, "Hypertensive heart disease (HHD) causes structural changes (e.g., fibrosis) that result in diastolic and systolic myocardial dysfunction. Alterations of P-31 metabolism and cardiac energy impairments were assessed in patients with HHD by MR spectroscopy (MRS) and correlated with left ventricular systolic function." "Thirty-six patients with HHD and 20 healthy controls (mean age 35.2±10.7 years) were examined with P-31-MRS at 1.5 T by using an...
Source: Telemedicine Business Week (2006-09-13)
|
